Nao Otsuka

Dr. Nao Otsuka

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2025 in Cancers
Verified
Journal Article
Open access
PDF file
NONao Otsuka
Nao Otsuka
YSYutaka Shimamatsu
Yutaka Shimamatsu
RHRyunosuke Hakuta
Ryunosuke Hakuta
YTYukiko Takayama
Yukiko Takayama
YNYousuke Nakai
Yousuke Nakai
With the increasing use of imaging modalities such as ultrasonography, computed tomography, and magnetic resonance imaging, incidental findings of pancreatic abnormalities, including pancreatic cysts and fatty pancreas (FP), have become more common. FP, also referred to as pancreatic steatosis, intra-pancreatic fat deposition, or fatty pancreas disease, is characterized by the accumulation of fat in the pancreas. Although FP has been associated with metabolic syndromes such as obesity and diabetes, its clinical significance remains unclear. Recent evidence suggests that FP may play a role in pancreatic carcinogenesis. Metabolic disorders, including obesity, insulin resistance, and diabetes, have been implicated in the development of FP. Additionally, FP has been linked to an increased risk of pancreatic ductal adenocarcinoma (PDAC), possibly due to chronic inflammation, lipotoxicity, and an altered pancreatic microenvironment. While early detection of PDAC remains challenging, surveillance strategies for high-risk individuals, such as those with pancreatic cysts, new-onset diabetes, or a genetic predisposition, may be crucial. In this context, FP may be incorporated into this surveillance of high-risk individuals. Some pharmacological interventions, including glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT2) inhibitors, have shown potential in reducing pancreatic fat accumulation, although further studies are needed to confirm their efficacy.

30 January 2026 in Clinical Endoscopy
Verified
Journal Article
Open access
YNYousuke Nakai
Yousuke Nakai
RHRyunosuke Hakuta
Ryunosuke Hakuta
YSYutaka Shimamatsu
Yutaka Shimamatsu
NONao Otsuka
Nao Otsuka
YTYukiko Takayama
Yukiko Takayama
Diagnosis of biliary strictures remains challenging because of the low sensitivity of conventional transpapillary sampling using endoscopic retrograde cholangiopancreatography. New devices and tips have been developed to increase the diagnostic yield of conventional transpapillary sampling. However, additional endoscopic procedures are often necessary for indeterminate biliary strictures. Two major approaches for indeterminate biliary strictures are endoscopic ultrasonography-guided sampling and peroral cholangioscopy (POCS)-guided biopsy. The selection of modalities should be considered based on the stricture location. Although endoscopic ultrasound is the preferred approach for distal biliary strictures, POCS is preferred for perihilar biliary strictures. Endoscopic ultrasonography-guided sampling is highly sensitive in cases with a mass, but the sensitivity of POCS-guided biopsies is unsatisfactory, and discrepancy with the visual diagnosis of POCS is common. Whether these advanced techniques should be performed as the initial procedure or as a rescue after a failed diagnosis by conventional transpapillary sampling needs to be clarified in terms of diagnostic yield and cost-effectiveness.

3 July 2026 in Digestive Endoscopy
Verified
Journal Article
Closed access
RHRyunosuke Hakuta
Ryunosuke Hakuta
RNRyota Nakabayashi
Ryota Nakabayashi
NONao Otsuka
Nao Otsuka
NINoriko Ishigaki
Noriko Ishigaki
YTYukiko Takayama
Yukiko Takayama
YNYousuke Nakai
Yousuke Nakai

30 October 2025 in The Korean Journal of Pancreas and Biliary Tract
Verified
Journal Article
Open access
PDF file
YNYousuke Nakai
Yousuke Nakai
RHRyunosuke Hakuta
Ryunosuke Hakuta
RNRyota Nakabayashi
Ryota Nakabayashi
YSYutaka Shimamatsu
Yutaka Shimamatsu
NONao Otsuka
Nao Otsuka
YTYukiko Takayama
Yukiko Takayama
Endoscopic ultrasound-guided biliary drainage (EUS-BD) has emerged as an important alternative to transpapillary biliary drainage by endoscopic retrograde cholangiopancreatography (ERCP) for malignant biliary obstruction (MBO), especially in cases with failed ERCP. Given the increasing evidences of safety and effectiveness of EUS-BD, EUS-BD as primary biliary drainage has been investigated in clinical trials. However, there are still obstacles that need to be addressed prior to clinical application. In this narrative review, clinical outcomes, hurdles and future perspectives of primary EUS-BD for MBO are discussed.

2 February 2026 in Digestive Endoscopy
Verified
Journal Article
Closed access
NONao Otsuka
Nao Otsuka
RHRyunosuke Hakuta
Ryunosuke Hakuta
YNYousuke Nakai
Yousuke Nakai